<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The activation of nuclear factor kappa B (NF-κB) p50/RelA is a key event in ischemic neuronal injury, as well as in brain ischemic tolerance </plain></SENT>
<SENT sid="1" pm="."><plain>We tested whether epigenetic mechanisms affecting the acetylation state of RelA might discriminate between neuroprotective and neurotoxic activation of NF-κB during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>NF-κB activation and RelA acetylation were investigated in cortices of mice subjected to preconditioning <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> or lethal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) and primary cortical neurons exposed to preconditioning or lethal oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation (OGD) </plain></SENT>
<SENT sid="3" pm="."><plain>In mice subjected to MCAO and in cortical neurons exposed to lethal OGD, activated RelA displayed a high level of Lys310 acetylation in spite of reduced total acetylation </plain></SENT>
<SENT sid="4" pm="."><plain>Also, acetylated RelA on Lys310 interacted strongly with the CREB-binding protein (CBP) </plain></SENT>
<SENT sid="5" pm="."><plain>Conversely, RelA activated during preconditioning <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> appeared deacetylated on Lys310 </plain></SENT>
<SENT sid="6" pm="."><plain>Overexpressing RelA increased <z:chebi fb="3" ids="33173">Bim</z:chebi> promoter activity and neuronal cell <z:hpo ids='HP_0011420'>death</z:hpo> both induced by lethal OGD, whereas overexpressing the acetylation-resistant RelA-K310R, carrying a mutation from Lys310 to arginine, prevented both responses </plain></SENT>
<SENT sid="7" pm="."><plain>Pharmacological manipulation of Lys310 acetylation by the sirtuin 1 activator <z:chebi fb="0" ids="27881">resveratrol</z:chebi> repressed the activity of the <z:chebi fb="3" ids="33173">Bim</z:chebi> promoter and reduced the neuronal cell loss </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that the acetylation of RelA in Lys310 dictates NF-κB-dependent pro-apoptotic responses and represents a suitable target to dissect pathological from neuroprotective NF-κB activation in <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
</text></document>